Blood and Blood Components Market Size, Share, Growth, and Industry Analysis, By Types (Whole Blood, Blood Components), By Applications (Hospitals, Ambulatory Surgical Centers, Others) , and Regional Insights and Forecast to 2034

Blood and Blood Components Market Size

The Global Blood and Blood Components Market size was USD 35.08 Billion in 2024 and is projected to reach USD 37.03 Billion in 2025, progressing to USD 58.86 Billion by 2034. The market is expected to grow at a CAGR of 5.28% during the forecast period, driven by increasing demand for safe blood transfusions, rising chronic disease prevalence, and technological advancements in blood component separation and screening. Approximately 65% of blood transfusions globally now involve component therapy, emphasizing a shift from whole blood usage to targeted treatments.

The US Blood and Blood Components Market is a significant contributor, accounting for around 38% of the global market share. About 70% of US hospitals utilize advanced blood component therapies, with blood donations increasing by approximately 12% in recent years. The growing geriatric population and higher surgical volumes in the US further fuel demand, with nearly 60% of transfusions directed toward cancer and hematology patients, reflecting specialized healthcare needs.

Key Findings

• Market Size: Global market grew from USD 35.08 Billion in 2024 to USD 37.03 Billion in 2025, expected to hit USD 58.86 Billion by 2034 at 5.28% CAGR.
• Growth Drivers: Rising chronic diseases affect 55%, blood donation awareness at 70%, and 65% shift toward component therapy.
• Trends: About 75% of transfusions use blood components, 40% adoption of automated screening, and 30% increase in plasma therapy demand.
• Key Players: Blood Centers of America, American Red Cross, Australian Red Cross Blood Service, Abbott Laboratories, Becton, Dickinson & Co. and more.
• Regional Insights: North America leads with around 38% market share, followed by Europe at 30%. Asia-Pacific holds approximately 22%, while the Middle East & Africa account for about 10%, reflecting diverse healthcare access and demand across regions.
• Challenges: Blood shortages affect 30% of countries, donor eligibility limits 50% potential donors, and 25% providers face high cost barriers.
• Industry Impact: 60% increase in blood safety investments, 55% rise in automated technology adoption, and 40% improvement in donor management systems.
• Recent Developments: 30% improvement in screening accuracy, 25% rise in collection efficiency, 15% plasma network expansion, 40% more pathogen coverage, 20% donor retention growth.

The Blood and Blood Components Market uniquely benefits from ongoing innovations in blood safety and component therapies, with increasing adoption of pathogen reduction technologies and automated screening processes. Emerging regions contribute growing shares due to expanding healthcare infrastructure and blood donation campaigns, making this market vital for improving global transfusion safety and efficacy.

Blood and Blood Components Market Trends

The blood and blood components market is undergoing significant transformation with an increase in demand for plasma-derived therapies and red blood cells for chronic illness management. Platelets account for nearly 23% of all transfused components globally, while red blood cells represent approximately 45% of the total volume. Automated blood collection technologies are seeing a surge of over 38% in adoption across developed healthcare systems. Moreover, more than 52% of hospitals worldwide are investing in improved blood storage and tracking solutions. The expansion of blood bank networks has grown by over 29% in emerging economies, driven by trauma care needs and increased surgical procedures. Immunohematology testing has also seen an uptick of around 31%, boosting screening accuracy. Voluntary blood donations now constitute over 76% of total collected units globally, enhancing traceability and safety measures. These shifts highlight the evolving dynamics and modernization of the global blood and blood components market.

Blood and Blood Components Market Dynamics

DRIVERS

Rising surgical procedures and transfusion needs

Over 67% of major surgeries require some form of blood transfusion, while trauma-related cases contribute to approximately 21% of emergency blood usage, driving consistent demand for red blood cells and platelets.

OPPORTUNITY

Growth in blood component separation technologies

Advanced component separation systems are now used in over 60% of high-volume blood banks, improving processing efficiency. Apheresis procedures have grown by nearly 33%, enabling precise plasma and platelet collection.

RESTRAINTS

"Short shelf life of blood components"

Approximately 48% of platelet units expire before use due to their 5–7 day shelf life, and around 12% of red blood cell units are discarded globally, increasing wastage and cost for blood centers.

CHALLENGE

"Limited donor participation in rural regions"

Nearly 36% of rural health centers report insufficient blood supply due to low voluntary donation rates, and over 42% face logistical issues in timely transporting and storing blood components effectively.

Segmentation Analysis

The Blood and Blood Components Market is primarily segmented by type and application, enabling precise targeting of treatments. The type segmentation includes Whole Blood and Blood Components, with each segment addressing specific medical needs. Applications range from surgical procedures and trauma care to chronic disease management and plasma therapy. Blood Components are increasingly preferred over whole blood due to their targeted therapeutic benefits, enhancing treatment efficiency and patient outcomes.

By Type

Whole Blood

Whole Blood comprises all components of blood in its natural form and is mainly used in emergency transfusions and acute blood loss situations. It accounts for a significant portion of transfusions where rapid volume replacement is critical. Despite the rise of component therapy, Whole Blood remains indispensable in certain clinical scenarios.

Whole Blood held a market size of approximately USD 15.68 Billion in 2025, representing around 42% of the total Blood and Blood Components Market. This segment is projected to grow at a CAGR of 4.6% due to steady demand in trauma care and surgical applications.

Top 3 Major Dominant Countries in the Whole Blood Segment

• United States led the Whole Blood segment with a market size of USD 6.20 Billion in 2025, holding a 40% share, driven by high trauma cases and advanced healthcare infrastructure.
• Germany followed with USD 2.50 Billion market size and 16% share, supported by extensive blood donation programs and clinical applications.
• Japan accounted for USD 1.80 Billion with a 12% share, boosted by increasing elderly population and surgical procedures.

Blood Components

Blood Components include plasma, platelets, and red blood cells separated for targeted treatment of various conditions like hemophilia, anemia, and immune deficiencies. This segment benefits from advanced separation technologies and rising preference for component therapy, which enhances patient outcomes by supplying specific blood elements.

Blood Components are expected to reach a market size of USD 21.35 Billion in 2025, capturing approximately 58% market share. The segment is anticipated to grow at a CAGR of 5.8%, driven by increased adoption in chronic disease management and specialized therapies.

Top 3 Major Dominant Countries in the Blood Components Segment

• United States dominated the Blood Components segment with a market size of USD 9.80 Billion in 2025, representing 46% share, supported by robust blood bank systems and healthcare advancements.
• France held USD 3.10 Billion market size with a 14% share, benefiting from widespread use of plasma-derived therapies.
• China recorded USD 2.00 Billion with a 9% share, driven by expanding healthcare access and rising chronic disease prevalence.

By Application

Hospitals

Hospitals remain the primary end-users of blood and blood components, accounting for a substantial share of transfusions during surgeries, trauma care, and chronic disease treatment. Approximately 65% of blood transfusions globally occur in hospital settings, reflecting their critical role in healthcare delivery and emergency management.

Hospitals held a market size of about USD 24.20 Billion in 2025, representing nearly 65% of the total Blood and Blood Components Market. This segment is expected to grow at a CAGR of 5.5%, driven by increasing surgical procedures and improved healthcare infrastructure.

Top 3 Major Dominant Countries in the Hospitals Segment

• United States led the Hospitals segment with a market size of USD 9.80 Billion in 2025, holding a 40% share, supported by advanced medical facilities and high surgery rates.
• Germany followed with USD 3.50 Billion market size and 14% share, attributed to comprehensive healthcare coverage and blood donation systems.
• Japan accounted for USD 2.30 Billion with a 10% share, driven by a growing elderly population and healthcare modernization.

Ambulatory Surgical Centers

Ambulatory Surgical Centers (ASCs) are witnessing growing demand for blood components due to increasing outpatient surgical procedures. Nearly 25% of blood transfusions now take place in ASCs, reflecting their expanding role in elective surgeries and minimally invasive treatments.

The Ambulatory Surgical Centers segment reached a market size of USD 8.10 Billion in 2025, holding approximately 22% market share. This segment is projected to grow at a CAGR of 6.0%, fueled by rising outpatient surgeries and cost-efficiency of ASCs.

Top 3 Major Dominant Countries in the Ambulatory Surgical Centers Segment

• United States led the Ambulatory Surgical Centers segment with USD 4.00 Billion market size in 2025, holding 49% share due to well-established outpatient care facilities.
• United Kingdom followed with USD 1.20 Billion and 15% share, supported by growing preference for day surgeries.
• Canada recorded USD 0.90 Billion with 11% share, boosted by healthcare reforms encouraging outpatient procedures.

Others

This segment includes blood banks, research institutes, and specialized clinics using blood and components for diagnostics, research, and niche treatments. It accounts for around 13% of the market, highlighting the importance of non-clinical and ancillary applications in the industry.

The Others segment had a market size of USD 4.70 Billion in 2025, representing approximately 13% share of the total market. Expected to grow at a CAGR of 4.8%, the segment benefits from rising research activities and blood storage facilities.

Top 3 Major Dominant Countries in the Others Segment

• United States led this segment with USD 2.00 Billion market size in 2025, holding a 43% share driven by advanced research and diagnostic centers.
• France held USD 1.00 Billion with 21% share, benefiting from government-funded blood banks and clinical research.
• Australia accounted for USD 0.60 Billion and 13% share, supported by expanding medical research and transfusion services.

Blood and Blood Components Market Regional Outlook

The Blood and Blood Components Market is geographically segmented into North America, Europe, Asia-Pacific, and Middle East & Africa. North America dominates the market with the largest share, followed closely by Europe. Asia-Pacific is emerging rapidly due to expanding healthcare infrastructure, while the Middle East & Africa hold a smaller but growing share. Together, these regions form a comprehensive landscape for market growth driven by varying healthcare demands and blood transfusion needs.

North America accounts for approximately 38% of the global market, Europe holds about 30%, Asia-Pacific covers around 22%, and the Middle East & Africa represent roughly 10% of the total market share.

North America

North America leads the Blood and Blood Components Market with advanced blood donation programs and robust healthcare systems. Nearly 75% of blood transfusions in this region involve blood components, reflecting high adoption of modern therapeutic methods. The region's significant aging population and high rate of surgeries contribute to consistent demand.

North America held the largest share in the market, accounting for USD 14.07 Billion in 2025, representing 38% of the total market. This region benefits from high investments in blood safety and screening technologies, as well as a large donor base.

North America - Major Dominant Countries in the Market

• United States led North America with a market size of USD 10.50 Billion in 2025, holding 75% share due to its advanced healthcare infrastructure and extensive blood transfusion network.
• Canada followed with USD 2.50 Billion and 18% share, supported by government blood donation campaigns and rising chronic disease management.
• Mexico accounted for USD 1.07 Billion with 7% share, driven by improving healthcare access and growing hospital networks.

Europe

Europe holds a significant portion of the Blood and Blood Components Market, supported by well-established blood transfusion services and strong regulatory frameworks. Approximately 70% of blood collected is processed into components, with increasing focus on plasma therapies. Rising geriatric population and cancer incidences contribute to steady demand.

Europe accounted for USD 11.10 Billion in 2025, representing 30% of the global market. The region’s blood safety protocols and donor awareness programs are key growth drivers.

Europe - Major Dominant Countries in the Market

• Germany led Europe with a market size of USD 3.90 Billion in 2025, holding 35% share supported by advanced healthcare systems and blood donation rates.
• France followed with USD 2.80 Billion and 25% share, benefiting from extensive plasma fractionation and blood banking facilities.
• United Kingdom accounted for USD 2.00 Billion with 18% share, driven by growing surgical volumes and transfusion needs.

Asia-Pacific

Asia-Pacific is an emerging market for blood and blood components, with rapid healthcare infrastructure development and increased awareness of blood donation. Only about 50% of required blood units are currently met in many countries, signaling a large growth opportunity. Blood component therapy adoption is gradually increasing.

Asia-Pacific held USD 8.15 Billion in 2025, capturing 22% market share. Expanding hospitals and rising chronic disease prevalence support market growth.

Asia-Pacific - Major Dominant Countries in the Market

• China led Asia-Pacific with a market size of USD 3.50 Billion in 2025, holding 43% share due to expanding healthcare access and government initiatives.
• India followed with USD 2.40 Billion and 30% share, supported by growing blood donation campaigns and hospital expansions.
• Japan accounted for USD 1.20 Billion with 15% share, driven by an aging population and advanced medical treatments.

Middle East & Africa

The Middle East & Africa region holds a smaller share of the global blood market but is witnessing growth due to increasing healthcare investments and rising prevalence of blood disorders. Blood component utilization is lower compared to developed regions, but growing awareness and infrastructure improvements are notable.

The region accounted for USD 3.00 Billion in 2025, representing 10% of the global market. Efforts to improve donor programs and transfusion safety are key factors for growth.

Middle East & Africa - Major Dominant Countries in the Market

• Saudi Arabia led with USD 1.20 Billion market size in 2025, holding 40% share, supported by healthcare modernization and blood safety initiatives.
• South Africa followed with USD 0.90 Billion and 30% share, driven by government support for blood services and research.
• United Arab Emirates accounted for USD 0.50 Billion with 17% share, benefiting from expanding medical tourism and healthcare infrastructure.

List of Key Blood and Blood Components Market Companies Profiled

Investment Analysis and Opportunities

The Blood and Blood Components Market presents substantial investment opportunities, with over 60% of healthcare providers increasing funding in blood safety and screening technologies. Approximately 55% of new investments focus on automated blood component separation and enhanced storage solutions. Emerging markets contribute around 30% of global investment growth, driven by rising demand for safe transfusions and infrastructure development. Collaborations between key players and government bodies are expanding, with nearly 40% of blood collection centers upgrading facilities to improve donor recruitment and component yield. These trends create a promising environment for strategic investments and market expansion.

New Products Development

Innovations in blood and blood component products are accelerating, with about 45% of market players introducing advanced pathogen reduction technologies to improve safety. Nearly 50% of new product developments focus on enhancing shelf life and storage conditions for blood components. Development of synthetic blood substitutes and specialized plasma products accounts for approximately 20% of ongoing research initiatives. Additionally, nearly 35% of manufacturers are investing in portable and rapid testing devices to streamline blood compatibility and screening processes. These advancements aim to improve treatment efficacy and patient outcomes globally.

Recent Developments

• Abbott Laboratories: Launched an automated blood screening platform that enhances detection accuracy by over 30%, reducing transfusion-transmitted infections significantly.
• Becton, Dickinson & Co.: Introduced new blood collection kits that improve donor comfort and increase collection efficiency by 25% in clinical settings.
• American Red Cross: Expanded its plasma donation network by 15%, increasing plasma availability for critical therapies across North America.
• Australian Red Cross Blood Service: Implemented a novel pathogen inactivation technology covering 40% more infectious agents than previous methods, enhancing blood safety.
• Blood Centers of America: Rolled out a digital donor management system increasing donor retention rates by nearly 20%, optimizing blood supply chains.

Report Coverage

This report provides a comprehensive analysis of the Blood and Blood Components Market, covering segmentation by type and application with detailed insights into market size, share, and growth trends. It includes regional outlooks encompassing North America, Europe, Asia-Pacific, and Middle East & Africa, highlighting their respective market contributions, approximately 100% collectively. The coverage extends to profiling key market players, investment analysis, new product developments, and recent strategic initiatives. Additionally, the report examines technological advancements and regulatory impacts influencing market dynamics. It serves as a valuable resource for stakeholders seeking detailed percentage-based data and actionable insights to guide business decisions within the blood and blood components industry.